Genzyme (GENZ) and Isis Pharma (ISIS) Announce Results of Mipomersen Phase 3's; Both Met Secondary Endpoints
Tweet Send to a Friend
Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals Inc. (Nasdaq: ISIS) today announced results of two phase 3 studies of mipomersen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
